Viral Infections & Virology

Welcome Message

About Conference

The 28th International Conference on Viral Infections & Virology, scheduled for September 25–26, 2025 in Paris, France, serves as a dedicated platform for exchanging ideas and knowledge in the field of virology. This scientific gathering brings together researchers, clinical experts, public health professionals, and academic leaders to explore the latest developments and challenges in understanding viral pathogens and related infections.

Theme: Revolutionizing Virology: Novel Technologies, Public Health Impact, and Future Challenges

Virology-2025 encourages open dialogue across multiple disciplines, focusing on recent findings in molecular virology, epidemiology, host-pathogen interactions, immune responses, and diagnostic advancements. The program includes keynote sessions, expert talks, poster discussions, and collaborative forums designed to support scientific progress and interdisciplinary collaboration.

With a focus on current trends and practical insights, the event provides valuable opportunities for attendees to share research, engage with peers, and contribute to the global virology landscape.

Why Should Attend?

Virology-2025 offers a unique opportunity to connect with global experts, researchers, and healthcare professionals who are driving advancements in the field of viral infections and virology. Through thought-provoking sessions and in-depth discussions, the conference fosters knowledge exchange and collaboration across academia, industry, and public health sectors.

Attendees will gain insights into emerging viral threats, diagnostic breakthroughs, vaccine strategies, and the latest scientific developments. Whether you are an early-career researcher, clinician, or policymaker, the conference provides a platform to explore innovative approaches and contribute to shaping future responses to viral challenges.

Join us in Paris this September to be part of an engaging scientific experience that promotes learning, idea-sharing, and professional growth in an ever-evolving field.

Benefits of Attending

• CPD-accredited participation certificate
• Indexed speaker and abstract visibility
• Abstracts featured in a high-traffic research library
• Interactive sessions for research teams
• Networking with virology experts worldwide
• Awards for young researchers and best posters
• Direct interaction with keynote presenters
• Insights into the latest virology advancements

Who Should Attend?

The 28th International Conference on Viral Infections & Virology, taking place on September 25–26, 2025 in Paris, France, is designed to gather a multidisciplinary audience involved in the study, prevention, and treatment of viral diseases. The event welcomes:

• Virologists
• Microbiologists
• Infectious Disease Specialists
• Epidemiologists and Public Health Experts
• Immunologists and Vaccine Researchers
• Clinical Researchers and Laboratory Scientists
• Healthcare Practitioners and Physicians
• Professors, Scholars, and Academic Researchers
• Graduate and Postgraduate Students
• Diagnostic and Biotechnology Companies
• Pharmaceutical Industry Professionals
• Global Health and Disease Surveillance Authorities
• Regulatory Bodies and Health Policy Advisors
• Medical and Scientific Associations

This conference provides a valuable forum to share research, build networks, foster collaboration, and explore the latest developments in virology and infectious disease science.

Session & Tracks

Track 1: Molecular Virology
This track focuses on the molecular structure, life cycle, and genetic dynamics of viruses. Topics include viral genome organization, replication strategies, mutation rates, and virus-host interactions at the cellular level. Discussions will explore how molecular insights contribute to understanding pathogenesis and guiding therapeutic design. Attendees will gain updated knowledge on molecular tools and methodologies used in virology research.

Track 2: Viral Immunology and Host Response
Explore how the immune system recognizes and responds to viral infections, from innate sensing to adaptive memory. This session covers cytokine signaling, immune evasion tactics, and implications for disease severity. Presentations will include research on T-cell responses, neutralizing antibodies, and immune-based interventions. The track offers valuable insights for vaccine development and immunotherapy.

Track 3: Emerging and Re-emerging Viruses
This session addresses the drivers behind the emergence and resurgence of viral pathogens, including environmental change, globalization, and host adaptation. Discussions will focus on surveillance systems, early outbreak detection, and containment strategies. Real-world case studies will highlight how cross-disciplinary collaboration enhances preparedness. Attendees will examine both known and newly identified viruses posing current health risks.

Track 4: Antiviral Research and Therapeutics
Gain insights into the development of antiviral compounds, treatment mechanisms, and resistance patterns. Topics will cover small-molecule inhibitors, monoclonal antibodies, and host-directed therapies. Emphasis will be placed on translational research bridging the lab and clinical settings. Sessions will also explore ongoing clinical trials and regulatory considerations for antiviral agents.

Track 5: Viral Diagnostics and Biomarkers
Learn about advancements in diagnostic platforms including PCR, CRISPR-based tools, and rapid antigen testing. This track covers the identification of biomarkers for early detection, disease progression, and treatment response. Experts will discuss the integration of diagnostics into outbreak response and patient care. Emphasis will also be placed on improving accuracy, accessibility, and turnaround time.

Track 6: Vaccines and Preventive Strategies
This session delves into the design, testing, and implementation of viral vaccines, including mRNA, vector-based, and protein subunit platforms. Topics include vaccine efficacy, duration of protection, and addressing global distribution challenges. Presenters will also examine strategies for improving vaccine uptake and addressing public hesitancy. Ongoing trials and emerging technologies will be reviewed.

Track 7: Viral Pathogenesis and Disease Mechanisms
Understand the complex pathways through which viruses cause disease in humans and animals. This track focuses on cellular damage, inflammation, and virus-mediated immune modulation. Sessions will examine acute and chronic disease models, latency, and viral oncogenesis. Presenters will explore the interplay between viral genetics and host susceptibility in determining disease outcomes.

Track 8: Zoonotic and Vector-Borne Viruses
Explore viruses that cross species barriers or are spread through arthropod vectors such as mosquitoes, ticks, and flies. This session covers spillover events, ecological factors, and surveillance in animal reservoirs. Discussions will highlight prevention strategies, vector control programs, and One Health approaches. Key examples include dengue, Zika, West Nile, and emerging zoonoses.

Track 9: Pediatric and Neonatal Viral Infections
This track highlights viral infections that disproportionately affect infants and young children. Topics include congenital infections, respiratory viruses, and age-specific immune responses. Experts will discuss diagnostic challenges, treatment protocols, and preventive measures for pediatric populations. Emphasis will be placed on long-term outcomes and vaccine strategies tailored for early life stages.

Track 10: Public Health, Policy, and Global Response
This session examines how policies and public health systems respond to viral threats at local and international levels. Topics include outbreak preparedness, risk assessment, and communication strategies. Real-world case studies will illustrate lessons learned from recent global health events. Attendees will explore the role of research, data sharing, and policy alignment in improving response effectiveness.

Track 11: RNA and DNA Viruses
This track explores the biology, replication strategies, and clinical impact of both RNA and DNA viruses. Sessions will highlight differences in mutation rates, genome stability, and replication mechanisms. Topics include retroviruses, herpesviruses, papillomaviruses, and coronaviruses. Researchers will present findings on how viral genome types influence pathogenesis and treatment approaches.

Track 12: Virus-Host Cell Interactions
Focuses on the dynamic relationship between viruses and host cells during infection. Discussions include viral entry, cellular signaling manipulation, and apoptosis evasion. This track highlights how viruses hijack host machinery for replication and survival. Understanding these interactions is crucial for identifying novel antiviral targets.

Track 13: Environmental and Waterborne Viruses
Covers the detection, transmission, and impact of viruses present in environmental reservoirs such as water, soil, and waste. This session addresses viral contamination, surveillance, and disinfection techniques. Case studies will include enteric viruses, norovirus outbreaks, and environmental virology methods. The track emphasizes public health relevance and prevention.

Track 14: Oncolytic and Cancer-Associated Viruses
Explores viruses that contribute to cancer development or serve as therapeutic tools against tumors. Topics include HPV, EBV, HBV, and oncolytic virotherapy. Sessions will examine molecular mechanisms of viral oncogenesis and tumor-selective viral replication. Attendees will learn about current strategies in viral-based cancer therapies.

Track 15: Viral Evolution and Adaptation
Discusses how viruses evolve under selective pressures, including host immunity and antiviral treatments. Topics cover genetic drift, recombination, and host-jumping events. This track explores how viral evolution shapes transmission dynamics and disease emergence. Case examples include influenza and SARS-CoV-2.

Track 16: Synthetic Virology and Genetic Engineering
Highlights the use of synthetic biology tools to design viral vectors, study gene functions, and develop therapeutics. Sessions will focus on genome editing, virus-like particles, and synthetic vaccine platforms. The track offers insights into engineered viruses for research and clinical applications.

Track 17: Plant and Agricultural Virology
Focuses on viruses affecting crops and agricultural ecosystems. Discussions include transmission by insects, resistance breeding, and economic impact. This track addresses the development of detection methods and sustainable management practices. Attendees will gain insight into the global relevance of plant virology.

Track 18: Animal Virology and Veterinary Research
Covers viral infections in livestock, companion animals, and wildlife. Sessions highlight zoonotic potential, vaccination strategies, and disease surveillance in veterinary settings. The track promotes interdisciplinary approaches linking animal and human health. Key topics include foot-and-mouth disease, avian influenza, and rabies.

Track 19: Neurological and Neurotropic Viruses
Examines viruses that affect the central nervous system and cause neurological complications. Topics include viral meningitis, encephalitis, and neuroinflammation. Presentations will cover both acute and chronic outcomes of neurotropic infections. Case studies include herpesviruses, flaviviruses, and enteroviruses.

Track 20: Viral Hepatitis and Liver Infections
Focuses on hepatitis viruses (A to E) and their impact on liver function and long-term health. Sessions include updates on diagnosis, treatment, and prevention. The track will cover chronic infection management, antiviral resistance, and liver cancer risk. Discussions emphasize global public health strategies.

Track 21: Respiratory Viruses and Pulmonary Infections
Highlights viral infections affecting the respiratory tract, including influenza, RSV, and coronaviruses. This track covers transmission, host response, and clinical management. Experts will present on pandemic preparedness, therapeutic advances, and vaccine development. Pediatric and geriatric considerations will also be addressed.

Track 22: Viral Epidemiology and Data Modeling
Covers tools and strategies used to track viral outbreaks, monitor spread, and predict future patterns. Topics include statistical modeling, genomic surveillance, and population-based studies. Sessions highlight how data inform response strategies and resource allocation. Real-time epidemiology will be explored using case examples.

Track 23: Virus-Induced Autoimmunity and Chronic Conditions
Examines how viral infections can trigger autoimmune responses and long-term health consequences. Topics include post-viral fatigue, Guillain-Barré syndrome, and chronic inflammation. This track highlights the need for longitudinal studies and personalized care approaches. Research into immune dysregulation will be a focus.

Track 24: Viral Bioinformatics and Genomics
Explores computational tools used to analyze viral genomes, mutation patterns, and evolution. Sessions include next-generation sequencing, phylogenetic analysis and viral metagenomics. This track is ideal for researchers interested in big data applications in virology. Real-world applications in diagnostics and epidemiology will be discussed.

Track 25: Ethics, Communication, and Public Trust in Virology
Focuses on ethical considerations in virology research, data sharing, and public communication. Topics include responsible messaging during outbreaks, misinformation challenges, and equity in access to care and vaccines. This track encourages dialogue between scientists, policymakers, and the public to foster trust in scientific processes.

Participation & Presentation Options

The 28th International Conference on Viral Infections & Virology (Virology-2025) offers a wide range of opportunities for academic and professional engagement. Whether you aim to present your research, gain exposure, or contribute to discussions on viral science and public health, there's a format to suit every interest:

Oral and Poster Presentations:
Present your original research through 15–20 minute oral talks or visually communicate your findings during poster sessions. Both formats encourage valuable exchanges with fellow researchers and domain experts.

E-Poster and Virtual Presentations:
Share your work through digital posters or participate virtually in live-streamed sessions. These formats offer global reach and flexibility for remote attendees and contributors.

Keynote/Invited Speaker:
Inspire a diverse audience with your expertise by presenting on high-impact topics in virology. Lead discussions that shape scientific thinking and future research directions.

Delegate Participation:
Join as a delegate to attend expert-led sessions, interact with global peers, and gain new insights across various disciplines in virology and infectious diseases.

Workshops and Symposia:
Lead interactive workshops or chair a focused symposium to explore specific themes such as viral diagnostics, immunology, or outbreak response strategies.

Exhibition and Sponsorship:
Showcase your institution, technologies, or research tools to a global audience. Connect with academic, clinical, and industry leaders through exhibition booths or partnership opportunities.

Virtual Participation:
Engage with the full conference experience from any location through real-time access to sessions, virtual networking tools, and digital resources.

Young Researcher Forum:
Early-career scientists are invited to present their work, receive feedback, and gain mentorship. This platform promotes visibility and professional growth in a supportive setting.

Panelist/Moderator Roles:
Contribute to panel discussions or moderate sessions on key issues in virology. Bring critical questions to the forefront and help facilitate meaningful dialogue.

How to Get Involved

• Register as an Attendee: Gain full access to scientific sessions, networking opportunities, and conference materials.
• Submit an Abstract: Share your work with the global community as an oral or poster presentation.
• Apply as a Speaker: Contribute your voice and insights by becoming a keynote or invited speaker.
• Host a Workshop or Symposium: Propose a specialized session that highlights emerging areas or collaborative solutions.
• Exhibit or Sponsor: Present your innovations and strengthen your presence in the virology community.
• Volunteer: Support the conference behind the scenes and contribute to its smooth execution.

Take the first step to join Virology-2025, a global platform to connect, collaborate, and contribute to the evolving field of virology—September 25–26, 2025, in Paris, France.

Market Analysis

The Virology sector in 2025 is experiencing notable growth, supported by a global emphasis on health preparedness, increased incidence of viral infections, and steady progress in research and laboratory technology. Conditions such as influenza, hepatitis, and newly identified pathogens are driving efforts in early detection and clinical response. The virology diagnostics field alone is projected to exceed USD 15 billion, thanks to improvements in molecular tools, sequencing techniques, and portable testing solutions. At the same time, targeted approaches using biologics and RNA-based platforms are helping improve patient outcomes.

Digital tools are becoming integral to how viral patterns are monitored, with data modeling, remote consultation systems, and AI-assisted tracking enhancing the speed and scope of response. Research institutes, public agencies, and Private organizations are working together to strengthen long-term strategies and system readiness. As integrated approaches like One Health gain traction, the virology field is becoming more collaborative and solution-driven. The developments unfolding in 2025 highlight virology’s expanding role in science, clinical care, and population-level health planning.

Here is a graph showing the growth of the virology sector from 2020 to 2025, with steady increases in both diagnostics and therapeutics markets. Let me know if you’d like to include additional categories, regions, or projections beyond 2025